Search

Investors
Australia offers a wealth
of opportunities

utility-emailutility-printutility-pdfContact usChange to standard fontChange to large font

Investor Update: BiotechnologyClick to subscribe to this Investor Updates RSS feed

PSL expands to Australia to meet demand from Asia
14 Jul 2014
UK-based Powder Systems Ltd (PSL), a pharmaceutical filtration, drying and containment manufacturer, has opened an office in Australia, expanding its operations to Perth on the back of growing demand from South-East Asia.
CSL establishes global manufacturing centre in Australia
25 May 2014
Australian biotechnology company, CSL Limited has established a new manufacturing facility in Melbourne as part of an A$257 million expansion to boost production of its popular blood plasma therapeutics.
Australian scientific investment helps develop artificial muscles with super human strength
9 Apr 2014
Australian scientists are part of an international collaboration that has developed artificial muscles from high-strength polymer fishing line. Produced by twisting and coiling the fishing line and applying heat, the scientists have produced muscles ...
Fresenius Kabi injects A$47 million into pharma manufacturing in Australia
4 Mar 2014
German healthcare company, Fresenius Kabi will invest A$47 million to expand its Australian operations with a new state-of-the-art pharmaceutical manufacturing facility in Melbourne.
Sanofi Pasteur enlists University of Melbourne to develop vaccines against infectious diseases
25 Feb 2014
Sanofi Pasteur, the vaccines division of the French integrated healthcare leader Sanofi, will partner with the University of Melbourne to work together to develop immune-boosters and vaccines.
Australian Government injects $25 million into nano-material research
23 Jan 2014
New advances in research on the use of smart nano-materials in biotech and clean energy will be made possible by a $25 million funding boost from the Australian Government.
Dutch pharmaceutical company opens $62m facility in Australia
14 Nov 2013
DSM Pharmaceutical Products has opened a new state-of-the-art biomanufacturing facility in Australia, underpinning the nation’s reputation for world-class medical innovation.
A$10 million for Australian bionic eye research
11 Jul 2013
The Australian government is providing an extra $A10 million to fund Australian researchers working to develop a bionic eye.
UQ hydrogen innovation wins joint investment from Government, French multinational
22 May 2013
French multi-national Air Liquide and the Australian Government’s Southern Cross Renewable Energy Fund have invested more than A$9 million in hydrogen storage technology developed by Australia’s University of Queensland (UQ).
Dutch pharmaceutical company to open plant in Australia
13 May 2013
DSM Pharmaceutical Products will open a new facility in Australia to manufacture drugs for early-stage clinical trials of treatment for arthritis, cancer and other diseases.

Site Information

Austrade makes no warranty, express or implied as to the fitness for a particular purpose, or assumes any legal liability for the accuracy or usefulness of any information contained in this document. Any consequential loss or damage suffered as a result of reliance on this information is the sole responsibility of the user.